[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368338-105":59,"doc-detail-368338-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","cancer-incidence-inconsistency-between-uk-biobank-participants-and-the-population-a-prospective-cohort-study","Cancer incidence inconsistency between UK Biobank participants and the population - a prospective cohort study","","Background: The UK Biobank is widely used in cancer research, yet its representativeness for cancer incidence has not been comprehensively evaluated. Methods: A prospective cohort study analyzed 466,163 UK Biobank participants cancer-free at recruitment. Standardised incidence ratios compared participant cancer incidences with UK national incidence for all cancers combined and 25 cancers. SIRs were assessed by age, sex, and deprivation. Results: Over a median 12-year follow-up, overall incidence was lower; most cancers showed lower rates that increased with deprivation. Conclusions: Inconsistencies may bias absolute risk estimates and calibration of cancer risk models.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-incidence-inconsistency-between-uk-biobank-participants-and-the-population-a-prospective-cohort-study/368338/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-incidence-inconsistency-between-uk-biobank-participants-and-the-population-a-prospective-cohort-study/368338.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main aim regarding the UK Biobank?","Question",{"text":113,"@type":114},"To compare cancer incidence among UK Biobank participants with population incidence for all cancers and 25 specific cancers, and to determine whether differences vary by demographic and socioeconomic factors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were cancer incidences compared in the study?",{"text":118,"@type":114},"By calculating standardised incidence ratios (SIRs) that contrast observed incidences in UK Biobank participants with UK national incidences, overall and for specific cancers.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results show about overall and cancer-specific incidence patterns?",{"text":122,"@type":114},"Overall cancer incidence in UK Biobank participants was lower than in the general population, and many cancer-specific SIRs differed from 1, with patterns varying by age, sex, and deprivation.",{"name":124,"@type":111,"acceptedAnswer":125},"Why could these incidence inconsistencies matter for cancer research?",{"text":126,"@type":114},"They can bias UK Biobank findings that rely on absolute cancer risks, such as development and validation of cancer risk models and penetrance estimates for cancer susceptibility genes.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},368338,1790198417,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Li etal. BMC Medicine (2025) 23:181  \n[https://doi.org/10.1186/s12916-025-03998-z](https://doi.org/10.1186/s12916-025-03998-z)  \nBMC Medicine  \n RESEARCH Open Access  \nCancer incidence inconsistency between UK Biobank participants and the population: a prospective cohort study  \nChenxi Li1,2, Gillian S. Dite 1, Tuong L. Nguyen 1, John L. Hopper 1 and Shuai Li 1*  \nAbstract  \nBackground While the UK Biobank has been widely used for cancer research, its representativeness of the population in terms of cancer incidence has not been thoroughly investigated.  \nMethods We conducted a prospective cohort study of 466,163 UK Biobank participants who were cancer-free at recruitment. Standardised incidence ratios (SIRs) were calculated for all cancers combined and for 25 cancers, by comparing incidences for the participants with the UK national incidences. Variations in SIR by age, sex and deprivation measures were investigated.  \nResults Over a median follow-up period of 12 years, 47,535 participants had a cancer diagnosis. The SIR for all cancers combined was 0.90 (95% CI: 0 . 89, 0 . 91) . The SIR increased with age and deprivation (P = 10−9) . The SIRs of 17 cancers differed from 1 (Bonferroni-adjusted P \u003C 0. 05): for prostate cancer and melanoma the SIRs were 1.2 and for the other 15 cancers the SIRs ranged from 0.43 to 0.93. The SIRs of 13 cancers differed by deprivation: the greater the deprivation, the lower the SIRs for prostate cancer and melanoma, and the higher the SIRs for the other 11 cancers. Conclusions The overall cancer incidence was 10% lower for the UK Biobank participants compared with the population, with most cancers having a lower incidence that increased with deprivation. Irrespective of their causes, the inconsistencies could bias UK Biobank research results related to absolute cancer risks, such as the development and/or validation of cancer risk models and penetrance estimates for cancer susceptibility genes.  \nKeywords UK Biobank, Cancer incidence, Absolute risk, Cohort study, Standardised incidence ratio, Healthy volunteer bias  \nBackground  \nThe UK Biobank is one of the world’s leading biobank cohorts which has recruited about 500,000 participants from 2006 to 2010 and followed them up for  \n*Correspondence:  \nShuai Li [shuai.li@unimelb.edu.au](shuai.li@unimelb.edu.au)  \n1 Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Carlton, VIC 3053, Australia  \n2 Children’s Hospital Westmead Clinical School, The University of Sydney, 1 King Street, Newtown, NSW 2042, Australia  \nclinical outcomes through linkage to medical records, and national cancer and death registries [1]. This resource has been widely used for medical and health research, especially for cancer research.  \nOne type of cancer research using the UK Biobank resource is to develop and/or validate cancer risk models, such as those for lung [2–4], colorectal [5, 6], prostate [7], pancreatic [8, 9], breast [10] and kidney cancers [11]. While most of these models reported good discrimination of cancer risk (i.e. to differentiate whether a person has cancer or not), the calibration of the models in a population setting (i.e. the agreement between the actual and estimated risk) relies on the cancer incidences for UK  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not per","cbCaiucj5Lg4dMbL","https://ap.wps.com/l/cbCaiucj5Lg4dMbL","pdf",1745989,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## UK Biobank and cancer research use\n## Impact on cancer risk model calibration\n## Prior evidence and remaining uncertainty","[{\"question\":\"What was the study’s main aim regarding the UK Biobank?\",\"answer\":\"To compare cancer incidence among UK Biobank participants with population incidence for all cancers and 25 specific cancers, and to determine whether differences vary by demographic and socioeconomic factors.\"},{\"question\":\"How were cancer incidences compared in the study?\",\"answer\":\"By calculating standardised incidence ratios (SIRs) that contrast observed incidences in UK Biobank participants with UK national incidences, overall and for specific cancers.\"},{\"question\":\"What did the results show about overall and cancer-specific incidence patterns?\",\"answer\":\"Overall cancer incidence in UK Biobank participants was lower than in the general population, and many cancer-specific SIRs differed from 1, with patterns varying by age, sex, and deprivation.\"},{\"question\":\"Why could these incidence inconsistencies matter for cancer research?\",\"answer\":\"They can bias UK Biobank findings that rely on absolute cancer risks, such as development and validation of cancer risk models and penetrance estimates for cancer susceptibility genes.\"}]","Cancer incidence inconsistency between UK Biobank participants and the population - a prospective cohort study | PDF",1790176394,25,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d10c865f0b13eec9d16d8751a410d978.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a31e75a9657f6d54fc44681cf6a64c03.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a4e50b86ae79527ea3c01dcb8d9299e.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c03a9e135cc9f828ea0a91e2d7597e08.webp",980,1301]